Live Stock News: Market Waiting to See if the President Says Something Exciting Today
Here's Why Pfizer (PFE) Is a Strong Value Stock
Jefferies Keeps Their Buy Rating on Pfizer (PFE)
Why Is Prem Watsa Bullish On Pfizer Inc. (PFE) Now?
The Past Three Years for Pfizer (NYSE:PFE) Investors Has Not Been Profitable
Pfizer To Go Ex-Dividend On January 24th, 2025 With 0.43 USD Dividend Per Share
Pfizer Options Spot-On: On January 22nd, 158.07K Contracts Were Traded, With 2.61 Million Open Interest
Wall Street Today: Does Anyone Have the Cash for Stargates
Live Stock: Stargate Rivals the Scale of the Manhattan Project, Musk Said it's a Pipe Dream
Takeda-backed Ascentage Pharma Sets Terms for $170M IPO
Why Pfizer (PFE) Outpaced the Stock Market Today
Wall Street Today: AI Domestic Investment News on the Way
Pfizer Options Spot-On: On January 21st, 140.67K Contracts Were Traded, With 3.26 Million Open Interest
Pfizer Unusual Options Activity For January 21
Live Stock News: Market Climbs, Crypto Falls, Big Tech is Here and Trump Starts Signing Orders
Why Is Pfizer Inc. (PFE) Among the Best High-Yield Dividend Stocks to Invest In?
Here Is What to Know Beyond Why Pfizer Inc. (PFE) Is a Trending Stock
Pfizer (NYSE:PFE) Is Paying Out A Larger Dividend Than Last Year
Why Pfizer (PFE) Is One of the Best Cheap Stocks to Buy for 2025?
Bernstein Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $32